Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
about
Pancreatic enzyme replacement therapy for people with cystic fibrosisMaintenance of nutritional status in patients with cystic fibrosis: new and emerging therapiesPancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extensionEnzyme replacement therapy for pancreatic insufficiency: present and futureStudy design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis.Pancreatic enzyme replacement therapy for people with cystic fibrosis.Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.Progress in cystic fibrosis and the CF Therapeutics Development NetworkPancreatic enzyme products: digesting the changes.Pancrelipase delayed-release capsules for the treatment of pancreatic insufficiency.Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.Staging chronic pancreatitis with exocrine function tests: Are we better?Less common etiologies of exocrine pancreatic insufficiency.Efficacy and safety of pancreatic enzyme replacement therapy on exocrine pancreatic insufficiency: a meta-analysis.
P2860
Q24193113-2B6C0E61-DB74-4EC5-A402-9D54A9A6FE77Q26858964-8B8BD438-B1F4-4D6E-9DFA-6AFD4A3855DBQ33446564-3A7A69A7-BFCD-4BC5-94E1-7A9C4F5FA7F8Q33449829-43250112-CAB1-4805-B6E9-162E5B923177Q33457034-CC261D8E-12F0-49FA-B96B-784BA0F41B9CQ34027667-118958B1-1463-41AB-A429-7BFC69651D1BQ34040502-BD58E1FD-FF96-46BE-8C16-BAB5C25FB911Q34137233-7300C832-BC4A-46BC-B154-1D2B96549099Q34149294-FFA329DC-B6E1-4B21-9CB4-BCC095B5D215Q34545623-5F9EA32A-F825-4ADA-A64F-4C786F07F583Q36184845-B792E6F5-D5E4-4749-8B06-364E9AD0582CQ36482162-6B2E4103-FA16-4213-8CBC-BEE10D3526C0Q37209004-63C96A40-EE86-4EE3-A5F3-9C243E8E2548Q37871722-590003F8-C1D1-41DC-8768-F56200E0AEC4Q42781022-B8C6A45F-7827-4A63-90DB-AFE5F5C04B8FQ45797776-27C2E902-CCEE-4809-B4D5-0B097BE641A9Q45807969-B17AF602-89B6-4B2D-AE7A-9A7ED0A8F3E1Q45914147-A62630DF-BB38-4575-9D46-F8EBEBC35AE9Q47132837-974C3489-A58D-413A-9066-6FC71483270B
P2860
Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@en
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@nl
type
label
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@en
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@nl
prefLabel
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@en
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@nl
P2093
P1476
Efficacy and safety of Creon 2 ...... ciency due to cystic fibrosis.
@en
P2093
Bruce C Trapnell
David Boyd
Gavin R Graff
Karen Maguiness
Katrin Beckmann
Steven Caras
P304
P356
10.1016/J.JCF.2009.08.008
P577
2009-10-07T00:00:00Z